cancer gene mutation refractory course change overnight promising way molecularly target abnormalities says director mgh east cancer center patients respond vaccines cancer manageable not curable haber says considered candidate immune treatment cancer patients undergo successful course targeted chemotherapy means patients responded conventional treatment eligible patients clinical remission tumors disappeared significantly reduced size given course immune treatment month rest period following chemotherapy successful phase iii lymphoma clinical trials course treatment consisted seven immunizations given 24 weeks standardized treatment protocol not developed probably vary according type cancer involved managing patients respond vaccine promises hope treatment gene targeted chemotherapy bridge path cure theoretically